Literature DB >> 15034672

[Interdisciplinary aspects of surgery of the pelvis minor and retroperitoneum].

R Ackermann1, M O Grimm, H G Bender, P Dall, M C Fleisch, W Hohenberger, J Göhl, S Merkel.   

Abstract

Surgery of diseases of the pelvis minor and retroperitoneum such as inflammatory disease, malignant tumours, or trauma of pelvic organs need the close interdisciplinary collaboration of visceral surgeons, gynaecologists, and urologists. This collaboration begins in planning diagnostic and therapeutic procedures. It has to be clear who performs which operative step and when. Excellent long-term results in malignant disease show that the greater effort is worthwhile. The rate of postoperative morbidity after these multivisceral resections is high also in specialised centers, but mortality is below 5%. Because of the growing number of long-term survivors, preservation of quality of life becomes more and more important.

Entities:  

Mesh:

Year:  2004        PMID: 15034672     DOI: 10.1007/s00104-004-0851-7

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  13 in total

Review 1.  Quality of life after rectal excision.

Authors:  W Hohenberger; B Bittorf
Journal:  Colorectal Dis       Date:  2003-05       Impact factor: 3.788

2.  Partial and complete pelvic exenteration for advanced and recurrent cancer.

Authors:  A BRUNSCHWIG
Journal:  W V Med J       Date:  1953-01

3.  Low rectal resection and anastomosis at the time of pelvic exenteration.

Authors:  K D Hatch; H M Shingleton; M E Potter; V V Baker
Journal:  Gynecol Oncol       Date:  1988-10       Impact factor: 5.482

4.  Rectal surgery for endometriosis--should we be aggressive?

Authors:  Nesrin Varol; Peter Maher; Martin Healey; Rod Woods; Carl Wood; David Hill; Nick Lolatgis; Jim Tsaltas
Journal:  J Am Assoc Gynecol Laparosc       Date:  2003-05

5.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

6.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

Authors:  Claus Rödel; Gerhard G Grabenbauer; Reinhard Kühn; Thomas Papadopoulos; Jürgen Dunst; Martin Meyer; Karl M Schrott; Rolf Sauer
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

7.  Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.

Authors:  R Sauer; R Fietkau; C Wittekind; C Rödel; P Martus; W Hohenberger; J Tschmelitsch; H Sabitzer; J-H Karstens; H Becker; C Hess; R Raab
Journal:  Colorectal Dis       Date:  2003-09       Impact factor: 3.788

Review 8.  Future directions in the surgical management of ovarian cancer.

Authors:  Michael L Berman
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

9.  Can neoadjuvant radiochemotherapy improve the results of multivisceral resections in advanced rectal carcinoma (cT4a).

Authors:  J Göhl; S Merkel; C Rödel; W Hohenberger
Journal:  Colorectal Dis       Date:  2003-09       Impact factor: 3.788

Review 10.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.